The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.
Haffner
S M
SM
Department of Medicine, University of Texas Health Science Center at San Antonio 78284-7873, USA.
D020909:Acarbose; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001161:Arteriosclerosis / Q000209:etiology* / Q000517:prevention & control; D001645:Biguanides / Q000494:pharmacology / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism / Q000502:physiology; D002318:Cardiovascular Diseases / Q000209:etiology* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000378:metabolism; D005215:Fasting / Q000378:metabolism / Q000502:physiology; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D006946:Hyperinsulinism / Q000150:complications / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D007328:Insulin / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019518:Postprandial Period / Q000502:physiology; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use; D014312:Trisaccharides / Q000494:pharmacology / Q000627:therapeutic use
D001645:Biguanides; D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D014312:Trisaccharides; D020909:Acarbose